Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Revenue

Ovid Therapeutics had revenue of $6.27M in the quarter ending June 30, 2025, with 3,611.24% growth. This brings the company's revenue in the last twelve months to $6.65M, up 1,070.95% year-over-year. In the year 2024, Ovid Therapeutics had annual revenue of $566.00K with 44.39% growth.

• Revenue (ttm): $6.65M
• Revenue Growth: +1,070.95%
• P/S Ratio: 14.63
• Revenue / Employee: $289,174
• Employees: 23
• Market Cap: 97.42M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	566.00K	174.00K	44.39%
Dec 31, 2023	392.00K	-1.11M	-73.91%
Dec 31, 2022	1.50M	-206.88M	-99.28%
Dec 31, 2021	208.38M	195.77M	1,551.57%
Dec 31, 2020	12.62M	-	-